Ah, thank you for the explanation -- I guess I rea
Post# of 148236
"The study will include a safety lead-in treating five patients in the 350 mg leronlimab arm..." So that is just for drug interactions, not "safety" in the bigger picture/full trial. 5 still seems oddly small to me for any kind of test, but what do I know...I guess drug interactions would be accurately measured with just 5 subjects. If you're fine with it, and Dr. L. is fine with it, it's fine with me!